0.69 USD
↗ 0.03 (4.99%)AT CLOSE (11:59 AM EDT)
AEON Biopharma, Inc.
AEONAMEX • USD
0.69
↘ 0.00 (0.01%)
POST MARKET (AS OF 07:49 PM EDT)
Post Market
AS OF 07:49 PM EDT
0.69
↘ 0.00 (0.01%)
Market: CLOSED
AEON is currently priced at $0.69. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (358.8%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Jun 23, 2026.
Open?$0.67
High?$0.70
Low?$0.63
Prev. Close?$0.66
Volume?23.8K
Avg. Volume?52.8K
VWAP?$0.66
Rel. Volume?0.45x
Bid / Ask
Bid?$0.65 × 100
Ask?$0.71 × 2.5K
Spread?$0.06
Midpoint?$0.68
Valuation & Ratios
Market Cap?17.4M
Shares Out?26.3M
Float?9.8M
Float %?81.1%
P/E Ratio?N/A
P/B Ratio?-1.04
EPS?-$2.28
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
Employees
8
Market Cap
17.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2023-07-24
Address
5 PARK PLAZA
IRVINE, CA 92614
Phone: (949) 354-6499
IRVINE, CA 92614
Phone: (949) 354-6499
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?63
Piotroski F-Score?0/9Weak
Altman Z-Score?-84.88Distress
Confidence?46%Low
Short InterestModerate
Short % of Float?2.23%Low
Short Interest?219.2K
Days to Cover?3.0
Free Float9.8M
Avg Daily Volume72.6K
Settlement Date2026-05-29
Financial Health
Current Ratio?0.99Weak
Quick Ratio?0.99Weak
Cash Ratio?0.94Adequate
Debt/Equity?-0.16Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-1.04CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.8CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?358.8%STRONG▾
Peers50
S&P97
ROA?-696.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-12035000
Enterprise Value?$13.8M
Fundamentals ratios updated end of day